Tonix Pharmaceuticals Holding Corp (TNXP)
0.14
0.00 (0.00%)
USD |
NASDAQ |
Nov 04, 16:00
0.1404
0.00 (0.00%)
After-Hours: 20:00
Tonix Pharmaceuticals Gross Profit Margin (Quarterly): -52.49% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -52.49% |
| March 31, 2024 | 33.12% |
| Date | Value |
|---|---|
| December 31, 2023 | 37.36% |
| September 30, 2023 | 40.49% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-52.49%
Minimum
Jun 2024
40.49%
Maximum
Sep 2023
14.62%
Average
35.24%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Emergent BioSolutions Inc | -19.35% |
| Geovax Labs Inc | -- |
| Abbott Laboratories | 55.83% |
| SIGA Technologies Inc | 30.31% |
| Chimerix Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -144.1% |
| Return on Assets | -119.4% |
| Return on Invested Capital | -147.9% |
| Profit Margin (Quarterly) | -3.57K% |
| Operating Margin (Quarterly) | -831.5% |
| Return on Net Operating Assets | -141.5% |